Menstrual Symptoms After COVID-19 Vaccine: A Cross-Sectional Investigation in the MENA Region
Nadia Muhaidat,Mohammad A Alshrouf,Muayad I Azzam,Abdulrahman M Karam,Majed Al-Nazer,Abdallah Al-Ani
DOI: https://doi.org/10.2147/IJWH.S352167
2022-03-29
Abstract:Nadia Muhaidat, 1 Mohammad A Alshrouf, 2 Muayad I Azzam, 2 Abdulrahman M Karam, 2 Majed W Al-Nazer, 2 Abdallah Al-Ani 3 1 Department of Obstetrics & Gynaecology, Jordan University Hospital, Amman, Jordan; 2 The School of Medicine, The University of Jordan, Amman, Jordan; 3 King Hussein Cancer Center, Amman, Jordan Correspondence: Nadia Muhaidat, Department of Obstetrics & Gynaecology, Jordan University Hospital, Queen Rania Street, Amman, 11942, Jordan, Tel +962 798385775, Email Background: Since the emergence of COVID-19 vaccinations, many women around the world are reporting abnormalities in their menstrual periods post-vaccination. The aim of this study is to investigate the prevalence and impact of menstrual abnormalities after the COVID-19 vaccine among females residing within the Middle East and North Africa (MENA). Methods: The study utilized a cross-sectional online self-administered survey from July 2021 to August 2021 targeting females living in the MENA region above the age of menarche who had received vaccine and were not pregnant or lactating, and do not have a history of primary ovarian insufficiency, hypothalamic menopause, or have undergone a hysterectomy. The survey was distributed regionally via social media. Results: A total of 2269 females were included in our study, with a mean age of 34.3 ± 8.5 years. About 66.3% of participants reported menstrual symptoms post-vaccination, of which 46.7% experienced them after their first dose. However, in 93.6% of participants, the symptoms resolved within 2 months. Vaccine type did not significantly influence the incidence of abnormalities (p > 0.05). Participants who had confirmed previous COVID-19 infection had a very similar percentage of menstrual abnormalities compared to people who did not have COVID-19 infection or symptoms suspected of COVID-19 infection and did not test (67.5%, 66.8%, respectively); nevertheless, those who had experienced the COVID-19 vaccine general side effects had significantly more abnormalities (p < 0.001). Compared to their pandemic status, females reported significantly more abnormalities post-vaccination. Conclusion: The study showed a possible link between the COVID-19 vaccine and menstrual abnormalities that have impacted their quality of life. Keywords: COVID-19, MENA, menstrual abnormalities, menstrual cycle, vaccine Over the past year and a half, the COVID-19 pandemic has taken the world by storm, affecting every aspect of human life. As a response, numerous vaccines were developed and approved in less than a year from when the virus was first identified. 1 By mid-2021, three billion doses had been administered around the world. 2 Nevertheless, this rapid worldwide use of the vaccines led the Centers for Disease Control and Prevention (CDC) to utilize a real-time Vaccine Adverse Event Reporting System called V-Safe to track potential side effects of the vaccine. 3 In addition, many studies reported a variety of vaccine-related side effects, ranging from mild symptoms like fever, chills, headache, fatigue, and arm pain to severe side effects such as thrombosis and anaphylaxis. 4–7 Moreover, a recent study reported several menstrual abnormalities following COVID-19 vaccination, including increased cycle length, pain, and bleeding. 8 The menstrual cycle reflects women's general health status, as women with irregular and longer menstrual cycles are at a higher risk of death before the age of 70. 9 This is partially attributed to women with irregular menstrual cycles being more prone to metabolic disorders such as diabetes mellitus and dyslipidemia. 10 Therefore, menstrual abnormalities pose a significant challenge for the healthcare system, particularly when accounting for its impact on women's daily tasks. 10 In light of the prevalence of menstrual abnormalities, 11,12 the American Academy of Pediatrics recommended adding the menstrual cycle to the vital signs of adolescent females. 13 The Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom reported 41,919 cases of menstrual problems, including heavier than usual periods, delayed periods, and unexpected vaginal bleeding, up to their latest update on 17/11/2021. 14 This emphasizes the importance of investigating menstrual abnormalities post COVID-19 vaccination. 15 Therefore, this study attempts to investigate the menstrual cycle abnormalities and their relation to the different types of COVID-19 vaccines, which will help us provide better medical care to achieve a satisfactory outcome for these patients by alleviating their conce -Abstract Truncated-